Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Betamethasone + Salicylic acid
- Therapeutic area
- Dermatology
- Drug class
- Topical corticosteroids / anti-inflammatory dermatologics
- ATC
- D07XC
- Strength
- 0.5 mg + 30 mg
- Dosage form
- Ointment
- Pack
- 15gm
- Registration no.
- 096920
- Price record verified
- 2026-08-08
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Caliph Pharmaceuticals (Pvt) Ltd.
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Betacline-S 0.5 mg + 30 mg ointment
Betacline-S 0.5 mg + 30 mg ointment contains Betamethasone + Salicylic acid 0.5 mg + 30 mg. It is registered with DRAP by Caliph Pharmaceuticals (Pvt) Ltd (registration no. 096920). Its official price is PKR 85.30 for a pack of 15gm. This price has applied since 1 July 2024. Betacline-S is also available as 0.05% + 2% lotion, 0.5 mg + 20 mg lotion and 0.5 mg/g + 30 mg/g ointment. 2 other brands of Betamethasone + Salicylic acid 0.5 mg + 30 mg (ointment) are registered in Pakistan. Compare all brands and prices →
Other strengths of Betacline-S
All 2 other brands of Betamethasone + Salicylic acid 0.5 mg + 30 mg ointment in Pakistan
These 2 brands are alternatives (substitutes) to Betacline-S: each contains Betamethasone + Salicylic acid 0.5 mg + 30 mg ointment. Ask your doctor or pharmacist before you switch brands.
Sorted by price per g, lowest first. The lowest is Valisone-S (CRYSTOLITE PHARMACEUTICALS) at PKR 6.68 per g; the highest is Anacor at PKR 7.01. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Valisone-S | CRYSTOLITE PHARMACEUTICALS | 15gm | PKR 100.16 | PKR 6.68 / g |
| Anacor | Shaigan Pharmaceuticals (Pvt) Ltd | 15gm | PKR 105.13 | PKR 7.01 / g |
See every strength and form of Betamethasone + Salicylic acid →
How old is this price? It was fixed on 1 July 2024 and has not changed since — that is 2 years ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Betacline-S, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Caliph Pharmaceuticals (Pvt) Ltd., Risalpur
- DRAP registration
- 096920
- Phone
- +92 339 4091138
- info@caliphpharma.com.pk
- Website
- https://www.caliphpharma.com.pk/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (15gm). Current price PKR 85.30, effective 1 Jul 2024.
Cite this price history
MedInfoBase. Betacline-S 0.5 mg + 30 mg, 15gm: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/betacline-s-0-5-mg-30-mg-096920-15gm-caliph-pharmaceuticals-pvt-ltd/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 85.30 | 2024-07-01 | 2026-08-08 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 096920Price and registration data on this page were observed on 8 August 2026. Records change over time, so please cite the observation date alongside the access date.